Normand Nadia, Valamanesh Fatemeh, Savoldelli Michèle, Mascarelli Frédéric, BenEzra David, Courtois Yves, Behar-Cohen Francine
INSERM U598, Paris, France.
Mol Vis. 2005 Mar 4;11:184-91.
To study VP22 light controlled delivery of antisense oligonucleotide (ODN) to ocular cells in vitro and in vivo.
The C-terminal half of VP22 was expressed in Escherichia coli, purified and mixed with 20 mer phosphorothioate oligonucleotides (ODNs) to form light sensitive complex particles (vectosomes). Uptake of vectosomes and light induced redistribution of ODNs in human choroid melanoma cells (OCM-1) and in human retinal pigment epithelial cells (ARPE-19) were studied by confocal and electron microscopy. The effect of vectosomes formed with an antisense ODN corresponding to the 3'-untranslated region of the human c-raf kinase gene on the viability and the proliferation of OCM-1 cells was assessed before and after illumination. Cells incubated with vectosomes formed with a mismatched ODN, a free antisense ODN or a free mismatched ODN served as controls. White light transscleral illumination was carried out 24 h after the intravitreal injection of vectosomes in rat eyes. The distribution of fluorescent vectosomes and free fluorescent ODN was evaluated on cryosections by fluorescence microscopy before, and 1 h after illumination.
Overnight incubation of human OCM-1 and ARPE-19 cells with vectosomes lead to intracellular internalization of the vectosomes. When not illuminated, internalized vectosomes remained stable within the cell cytoplasm. Disruption of vectosomes and release of the complexed ODN was induced by illumination of the cultures with a cold white light or a laser beam. In vitro, up to 60% inhibition of OCM-1 cell proliferation was observed in illuminated cultures incubated with vectosomes formed with antisense c-raf ODN. No inhibitory effect on the OCM-1 cell proliferation was observed in the absence of illumination or when the cells are incubated with a free antisense c-raf ODN and illuminated. In vivo, 24 h after intravitreal injection, vectosomes were observed within the various retinal layers accumulating in the cytoplasm of RPE cells. Transscleral illumination of the injected eyes with a cold white light induced disruption of the vectosomes and a preferential localization of the "released" ODNs within the cell nuclei of the ganglion cell layer, the inner nuclear layer and the RPE cells.
In vitro, VP22 light controlled delivery of ODNs to ocular cells nuclei was feasible using white light or laser illumination. In vivo, a single intravitreal injection of vectosomes, followed by transscleral illumination allowed for the delivery of free ODNs to retinal and RPE cells.
研究体外和体内VP22介导的反义寡核苷酸(ODN)对眼细胞的光控递送。
VP22的C端半段在大肠杆菌中表达、纯化,并与20聚硫代磷酸酯寡核苷酸(ODNs)混合形成光敏复合颗粒(载体体)。通过共聚焦显微镜和电子显微镜研究载体体在人脉络膜黑色素瘤细胞(OCM-1)和人视网膜色素上皮细胞(ARPE-19)中的摄取以及光诱导的ODN重新分布。评估由与人c-raf激酶基因3'-非翻译区对应的反义ODN形成的载体体在光照前后对OCM-1细胞活力和增殖的影响。用错配ODN、游离反义ODN或游离错配ODN形成的载体体孵育的细胞作为对照。在大鼠眼玻璃体内注射载体体24小时后进行经巩膜白光照射。在光照前和光照后1小时,通过荧光显微镜评估冷冻切片上荧光载体体和游离荧光ODN的分布。
人OCM-1和ARPE-19细胞与载体体过夜孵育导致载体体内化到细胞内。未光照时,内化的载体体在细胞质内保持稳定。用冷白光或激光束照射培养物可诱导载体体破坏并释放复合的ODN。在体外,在用反义c-raf ODN形成的载体体孵育的光照培养物中,观察到OCM-1细胞增殖受到高达60%的抑制。在无光照或细胞与游离反义c-raf ODN孵育并光照时,未观察到对OCM-1细胞增殖的抑制作用。在体内,玻璃体内注射24小时后,在视网膜各层中观察到载体体积聚在RPE细胞的细胞质中。用冷白光经巩膜照射注射的眼睛可诱导载体体破坏,并使“释放”的ODN优先定位在神经节细胞层、内核层和RPE细胞的细胞核内。
在体外,使用白光或激光照射,VP22介导的ODN向眼细胞核的光控递送是可行的。在体内,单次玻璃体内注射载体体,随后经巩膜照射可将游离ODN递送至视网膜和RPE细胞。